Ibenal Forte

Ibuprofen, the active ingredient in Ibenal Forte, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is used to relieve pain, reduce fever, and lessen inflammation in adults and children when prescribed.

GNH USA supplies Ibenal Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts systemically to control inflammation‑mediated conditions and associated symptoms.

Pain: provides analgesia for mild to moderate musculoskeletal, dental and postoperative pain. Fever: lowers elevated body temperature in febrile states. Inflammation: reduces swelling and stiffness in conditions such as arthritis and soft‑tissue injuries.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort, such as dyspepsia or heartburn. - Nausea or occasional vomiting. - Headache or dizziness. - Mild skin rash or itching. - Elevated blood pressure in susceptible individuals.

Serious or Rare Side Effects: - Gastrointestinal bleeding, ulceration or perforation. - Acute renal impairment or failure. - Severe hypersensitivity reactions, including anaphylaxis. - Hepatotoxicity presenting as jaundice or elevated liver enzymes. - Cardiovascular events such as myocardial infarction or stroke. - Hematologic abnormalities like thrombocytopenia.

Before initiating ibuprofen therapy, consider patient‑specific risk factors and monitor appropriately.

Assess gastrointestinal risk: evaluate history of ulcers or bleeding. Monitor renal function: especially in patients with chronic kidney disease or dehydration. Use lowest effective dose: to achieve therapeutic goal while limiting exposure. Avoid in known hypersensitivity: discontinue if allergic reactions occur. Caution with anticoagulants: increased bleeding risk when combined. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Ibuprofen can alter the pharmacodynamics or pharmacokinetics of several medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - ACE inhibitors or ARBs: may reduce renal perfusion. - Lithium: increased serum lithium levels. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in antihypertensive effect. - Corticosteroids: synergistic risk of ulceration. - SSRIs or SNRIs: modest increase in bleeding tendency. - Beta‑blockers: may blunt antihypertensive response. - Antihypertensive agents: monitor blood pressure for changes.